Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition

por Cavasin, Maria A, Demos-Davies, Kimberly M, Schuetze, Katherine B, Blakeslee, Weston W, Stratton, Matthew S, Tuder, Rubin M, McKinsey, Timothy A
Publicado 2014

Histone Deacetylase Adaptation in Single Ventricle Heart Disease and a Young Animal Model of Right Ventricular Hypertrophy

por Blakeslee, Weston W., Demos-Davies, Kimberly M., Lemon, Douglas D., Lutter, Katharina M., Cavasin, Maria A., Payne, Sam, Nunley, Karin, Long, Carlin S., McKinsey, Timothy A., Miyamoto, Shelley D.
Publicado 2017

Endoplasmic Reticulum Stress Effector CCAAT/Enhancer‐binding Protein Homologous Protein (CHOP) Regulates Chronic Kidney Disease–Induced Vascular Calcification

por Miyazaki‐Anzai, Shinobu, Masuda, Masashi, Demos‐Davies, Kimberly M., Keenan, Audrey L., Saunders, Sommer J., Masuda, Rumiko, Jablonski, Kristen, Cavasin, Maria A., Kendrick, Jessica, Chonchol, Michel, McKinsey, Timothy A., Levi, Moshe, Miyazaki, Makoto
Publicado 2014

DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy

por Ferguson, Bradley S., Wennersten, Sara A., Demos-Davies, Kimberly M., Rubino, Marcello, Robinson, Emma L., Cavasin, Maria A., Stratton, Matthew S., Kidger, Andrew M., Hu, Tianjing, Keyse, Stephen M., McKnight, Robert A., Lane, Robert H., Nozik, Eva S., Weiser-Evans, Mary C. M., McKinsey, Timothy A.
Publicado 2021